Drug Enforcement Controlled Substances Regulatory Policy Updates
This update covers drug enforcement controlled substances regulatory policy changes relevant to cannabis clinicians. It highlights new scheduling of synthetic cannabinoids and benzodiazepine analogs. Clinicians should stay informed on these regulatory…
Cannabis Wellness Frontiers: 6 Emerging Areas Worth Watching, and What the Evidence Actually Shows
Cannabis wellness frontiers are expanding with promising research in areas like wound healing, endometriosis, and brain injury recovery. This physician-guided review clarifies what the evidence actually shows. It highlights six emerging areas worth…
CED Regulatory Digest: Latest Cannabinoid Labeling Guidance Updates
This CED Regulatory Digest covers the latest cannabinoid labeling guidance updates from the FDA docket. It highlights key compliance posture changes and agency comment reviews. Stay informed on regulatory developments affecting cannabinoid products.
Research Suggests Cannabis Is Ineffective for Depression, Anxiety or PTSD
Cannabis psychiatric research findings reveal mixed results for depression, anxiety, and PTSD. This nuanced evidence highlights the importance of individualized treatment approaches. Clinicians should consider specific cannabinoid profiles and dosing…
Specific Forms of Substance Misuse Increase Stroke Risk – Psychiatry Advisor
Stroke risk assessment substance use is essential for identifying cerebrovascular dangers linked to different substances. Emerging evidence shows varying stroke risks depending on substance class and use patterns. Clinicians must incorporate…
Effects of Cannabidiol on Social Relating, Anxiety, and Parental Stress in Autistic Children
This study explores CBD autism social communication effects on anxiety and parental stress in autistic children. Findings suggest modest improvements in social relating and reduced parental stress. These preliminary results highlight potential benefits…
Artelo Biosciences Expands into Glaucoma Market with New Study – Intellectia AI
Artelo Biosciences glaucoma study highlights cannabinoids' potential for intraocular pressure reduction and neuroprotection. This clinical research advances understanding of cannabinoid therapeutic targets in glaucoma. Ongoing studies aim to optimize…
University of Calgary Scientists Study Optimal THC Dosage for Therapeutic Use
THC dosing clinical research addresses the challenge of standardizing therapeutic windows for cannabis treatment. University of Calgary scientists study optimal THC dosage to improve clinical protocols. This research aims to provide evidence-based…
How to Match Cannabis to Your Specific Insomnia Type
This cannabis insomnia guide helps readers understand different sleep problems and how cannabis can be matched to each type. It covers falling asleep, staying asleep, nighttime anxiety, and grogginess. Personalized cannabis dosing and timing are key to…
Cannabis for Pain Management: A Smarter Way to Think About Relief
Cannabis for pain relief requires matching the product, dose, and timing to the specific type of pain you have. Effective pain management with cannabis involves understanding cannabinoid roles and delivery methods. This guide helps you think clearly…